Linda, it's not personal
I'm sure all you said about Cacaito is true. He may not have a position in Zona but perhaps he has one in a competitor. His profile shows quite a few posts on the Vivus thread.
It just seemed clear to me that his post was intended as some kind of a slight towards Zonagen. Point is, why do so many keep dragging out old, irrelevant information in an effort to malign this company. The study he referenced is OLD NEWS - it can, on superficial examination, be seen as casting doubt on the viability of Phentolamine for ED. Other interpretations could be taken as positive (see Bruce's response). There are more recent, and better designed, phase III studies that more accurately address this point.
If I missed something here then I apologize to Cacaito.
This is just getting so silly - let the professionals involved, Zona, SGP, patent office, FDA, etc. do their work. Hopefully, significant news will be forthcoming soon and we can move beyond the "alternative" motives of some recent posters on this thread. |
